Borderline personality disorder. (Q54161660)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Borderline personality disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

borderline personality disorder

19 January 2020

main subject

0 references

author

Antonia S New

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

Falk Leichsenring

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Eric Leibing

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Johannes Kruse

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Frank Leweke

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

9759

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

74-84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

Treatment utilization by patients with personality disorders.

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The borderline diagnosis I: psychopathology, comorbidity, and personality structure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Borderline personality disorder and suicidality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The Collaborative Longitudinal Personality Disorders Study (CLPS): overview and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

DSM-IV personality disorders in the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The Prevalence of Personality Disorders in a Community Sample

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Borderline personality disorder: ontogeny of a diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Borderline personality disorder in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Diagnostic efficiency of DSM-IV criteria for borderline personality disorder: an evaluation in Hispanic men and women with substance use disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Longitudinal diagnostic efficiency of DSM-IV criteria for borderline personality disorder: a 2-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Confirmatory factor analysis of DSM-IV criteria for borderline personality disorder: findings from the collaborative longitudinal personality disorders study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Plausibility and possible determinants of sudden "remissions" in borderline patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Major depressive disorder and borderline personality disorder revisited: longitudinal interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The Subsyndromal Phenomenology of Borderline Personality Disorder: A 10-Year Follow-Up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Ten-year stability and latent structure of the DSM-IV schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The longitudinal relationship of personality traits and disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The stability of personality traits in individuals with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Five year follow-up comparison of borderline and schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The interface between borderline personality disorder and bipolar spectrum disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Borderline personality or complex posttraumatic stress disorder? An update on the controversy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Functional Impairment in Patients With Schizotypal, Borderline, Avoidant, or Obsessive-Compulsive Personality Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The 10-year course of psychosocial functioning among patients with borderline personality disorder and axis II comparison subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Severity of reported childhood sexual abuse and its relationship to severity of borderline psychopathology and psychosocial impairment among borderline inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

TRAUMATIC EXPOSURE AND POSTTRAUMATIC STRESS DISORDER IN BORDERLINE, SCHIZOTYPAL, AVOIDANT, AND OBSESSIVE-COMPULSIVE PERSONALITY DISORDERS: FINGINGS FROM THE COLLABORATIVE LONGITUDINAL PERSONALITY DISORDERS STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Borderline Personality Disorder and childhood sexual abuse: a meta-analytic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The nature of borderline personality disorder: multiple dimensions, multiple symptoms, but one category

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Mind, brain, and personality disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The 5-HTTLPR polymorphism modulates the association of serious life events (SLE) and impulsivity in patients with Borderline Personality Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Modulatory role of the brain-derived neurotrophic factor Val66Met polymorphism on the effects of serious life events on impulsive aggression in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The borderline diagnosis III: identifying endophenotypes for genetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Dimensional representations of DSM-IV cluster B personality disorders in a population-based sample of Norwegian twins: a multivariate study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The borderline diagnosis II: biology, genetics, and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Recent advances in the biological study of personality disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Association between serotonin transporter gene and borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Failure to detect an association between the serotonin transporter gene and borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Interaction between gene variants of the serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT) in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Serotonin genes and gene-gene interactions in borderline personality disorder in a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Monoamine oxidase a gene is associated with borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The Dexamethasone Suppression Test and Glucocorticoid Receptors in Borderline Personality Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The hypothalamic-pituitary-adrenal axis in borderline personality disorder: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Orbitofrontal, amygdala and hippocampal volumes in teenagers with first-presentation borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse--a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Volumes of the hippocampus and amygdala in patients with borderline personality disorder: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Amygdala-prefrontal disconnection in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Frontolimbic structural changes in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Pituitary volume in teenagers with first-presentation borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

An MRI study of pituitary volume and parasuicidal behavior in teenagers with first-presentation borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Reduced size and abnormal asymmetry of parietal cortex in women with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Size abnormalities of the superior parietal cortices are related to dissociation in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Reduced prefrontal and orbitofrontal gray matter in female adolescents with borderline personality disorder: is it disorder specific?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Positron emission tomography in female patients with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Neural correlates of emotion processing in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Functional MRI correlates of the recall of unresolved life events in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Neural correlates of the use of psychological distancing to regulate responses to negative social cues: a study of patients with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Posttraumatic stress disorder and fMRI activation patterns of traumatic memory in patients with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Amygdala deactivation as a neural correlate of pain processing in patients with borderline personality disorder and co-occurrent posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Efficacy of phenelzine and haloperidol in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

A trial of carbamazepine in borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Olanzapine versus haloperidol in the management of borderline personality disorder: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Clonidine improves hyperarousal in borderline personality disorder with or without comorbid posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Pharmacotherapy for borderline personality disorder: NICE guideline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Cognitive-Behavioral Treatment of Chronically Parasuicidal Borderline Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Dialectical Behavior Therapy of borderline patients with and without substance use problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Efficacy of dialectical behavior therapy in women veterans with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Cognitive therapy versus Rogerian supportive therapy in borderline personality disorder. Two-year follow-up of a controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Treating co-occurring Axis I disorders in recurrently suicidal women with borderline personality disorder: a 2-year randomized trial of dialectical behavior therapy versus community treatment by experts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Two-Year Randomized Controlled Trial and Follow-up of Dialectical Behavior Therapy vs Therapy by Experts for Suicidal Behaviors and Borderline Personality Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Dialectical behaviour therapy skills training compared to standard group therapy in borderline personality disorder: a 3-month randomised controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Manual assisted cognitive treatment for deliberate self-harm in borderline personality disorder patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Implementation of outpatient schema therapy for borderline personality disorder with versus without crisis support by the therapist outside office hours: A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Change in attachment patterns and reflective function in a randomized control trial of transference-focused psychotherapy for borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Psychotherapy of borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Dimensional representations of DSM-IV personality disorders: relationships to functional impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

Critical developments in the assessment of personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961422-5

7 January 2021

10.1016/S0140-6736(10)61422-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195251%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference